U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036419) titled 'A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients' on June 16.

Brief Summary: The study is being conducted to evaluate the efficacy and safety of Remimazolam for intraoperative sedation in pediatric and adolescent patients.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Operative Sedation of Pediatric Operative Sedation of Adolescent Patients

Intervention: DRUG: Remimazolam Tosilate for injection

Remimazolam Tosilate for injection.

DRUG: Propofol Injection

Propofol injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Discla...